3h
The urinary symptoms most people ignore until it’s too late, doctor explains the hidden cancer risk
Most people do not rush to a doctor for urinary discomfort. A little burning sensation, frequent bathroom visits at night, or ...
Researchers have found in a new study that the success rates of root canal treatment (RCT) in patients with autoimmune ...
Moby summary of Cellectar Biosciences, Inc.'s Q1 2026 earnings call ...
The current prior authorization (PA) process is an administrative failure. Beyond the excessive time and paperwork required, ...
Resurge Therapeutics, a clinical-stage urology company, today announced positive clinical results from two studies evaluating its proprietary IntraProstatic Drug Elution (IPDE) therapy. The IPDE ...
Iopofosine I-131 achieved an overall response rate of 83.6% and a major response rate of 61.8% in patients with relapsed or ...
19h
Solid Tumor Treatment Race Heats Up as Multi-Billion-Dollar Oncology Market Enters High-Growth Phase
Momentum around solid tumor cancer treatments is picking up fast as new technologies and therapies continue delivering ...
The bacteria that cause tuberculosis can survive for months in damp, poorly ventilated spaces that receive little to no ...
Q1 2026 Earnings Call May 14, 2026 4:30 PM EDTCompany ParticipantsDavid Krempa - Chief Business OfficerSean Brynjelsen ...
Preconditioning-free (PC-free) 6-to-9-month clinical data with a single infusion of the lowest dose of rese-cel in the RESET-PV ® study presented today at ASGCT 2026 Annual Meeting along with initial ...
Biogen Inc. (Nasdaq: BIIB) today announced the successful completion of the acquisition of Apellis Pharmaceuticals, Inc.
Bank of America Global Healthcare Conference 2026 May 14, 2026 11:40 AM EDTCompany ParticipantsAdam Lenkowsky - ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results